| Estimating the impact of adherence to and persistence with atypical antipsychotic therapy on health care costs and risk of hospitalization Y Jiang, W Ni Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 35 (9 …, 2015 | 57 | 2015 |
| Effectiveness of remdesivir for the treatment of hospitalized COVID‐19 persons: a network meta‐analysis Y Jiang, D Chen, D Cai, Y Yi, S Jiang Journal of medical virology 93 (2), 1171-1174, 2021 | 56 | 2021 |
| Effectiveness of inactivated COVID-19 vaccines against illness caused by the B. 1.617. 2 (Delta) variant during an outbreak in Guangdong, China: a cohort study M Kang, Y Yi, Y Li, L Sun, A Deng, T Hu, J Zhang, J Liu, M Cheng, S Xie, ... Annals of internal medicine 175 (4), 533-540, 2022 | 51 | 2022 |
| Estimation of the cost-effective threshold of a quality-adjusted life year in China based on the value of statistical life D Cai, S Shi, S Jiang, L Si, J Wu, Y Jiang The European Journal of Health Economics, 1-9, 2022 | 43 | 2022 |
| A retrospective cohort study of acute kidney injury risk associated with antipsychotics Y Jiang, JS McCombs, SH Park CNS drugs 31, 319-326, 2017 | 43 | 2017 |
| Adults with type 1 diabetes: Partner relationships and outcomes PM Trief, Y Jiang, R Beck, PJ Huckfeldt, T Knight, KM Miller, ... Journal of Health Psychology 22 (4), 446-456, 2017 | 28 | 2017 |
| COVID-19 vaccine uptake and hesitancy among HIV-infected men who have sex with men in mainland China: a cross-sectional survey W Zheng, Y Sun, H Li, H Zhao, Y Zhan, Y Gao, Y Hu, P Li, YF Lin, H Chen, ... Human Vaccines & Immunotherapeutics 17 (12), 4971-4981, 2021 | 27 | 2021 |
| Effectiveness of inactivated COVID-19 vaccines against COVID-19 pneumonia and severe illness caused by the B. 1.617. 2 (Delta) variant: evidence from an outbreak in Guangdong … M Kang, Y Yi, Y Li, L Sun, A Deng, T Hu, J Zhang, J Liu, M Cheng, S Xie, ... | 27 | 2021 |
| The cost-effectiveness of conducting three versus two reverse transcription-polymerase chain reaction tests for diagnosing and discharging people with COVID-19: evidence from … Y Jiang, D Cai, D Chen, S Jiang BMJ global health 5 (7), e002690, 2020 | 23 | 2020 |
| Economic evaluations of inactivated COVID-19 vaccines in six Western Pacific and South East Asian countries and regions: A modeling study Y Jiang, D Cai, S Shi Infectious Disease Modelling 7 (1), 109-121, 2022 | 19 | 2022 |
| Economic evaluation of remdesivir for the treatment of severe COVID‐19 patients in China under different scenarios Y Jiang, D Cai, D Chen, S Jiang, L Si, J Wu British Journal of Clinical Pharmacology 87 (11), 4386-4396, 2021 | 17 | 2021 |
| Expected lifetime numbers, risks, and burden of osteoporotic fractures for 50-year old Chinese women: a discrete event simulation incorporating FRAX Y Jiang, W Ni Journal of bone and mineral metabolism 34, 714-722, 2016 | 17 | 2016 |
| Incorporating productivity loss in health economic evaluations: a review of guidelines and practices worldwide for research agenda in China S Jiang, Y Wang, L Si, X Zang, YY Gu, Y Jiang, GG Liu, J Wu BMJ Global Health 7 (8), e009777, 2022 | 16 | 2022 |
| Performance of unanchored matching-adjusted indirect comparison (MAIC) for the evidence synthesis of single-arm trials with time-to-event outcomes Y Jiang, W Ni BMC medical research methodology 20, 1-9, 2020 | 16 | 2020 |
| Impact of supplementary private health insurance on hospitalization and physical examination in China Y Jiang, W Ni China Economic Review 63, 101514, 2020 | 16 | 2020 |
| A model for assessing the clinical and economic benefits of bone-forming agents for reducing fractures in postmenopausal women at high, near-term risk of osteoporotic fracture CE O’Hanlon, A Parthan, M Kruse, S Cartier, B Stollenwerk, Y Jiang, ... Clinical Therapeutics 39 (7), 1276-1290, 2017 | 16 | 2017 |
| Cost-effectiveness and value-based prices of the 9-valent human papillomavirus vaccine for the prevention of cervical cancer in China: an economic modelling analysis Y Jiang, W Ni, J Wu BMJ open 9 (11), e031186, 2019 | 15 | 2019 |
| Clozapine revisited: impact of clozapine vs olanzapine on health care use by schizophrenia patients on Medicaid KL Thomas, Y Jiang, JS McCombs , 27, 2 27 (2), 90-99, 2015 | 15 | 2015 |
| Impact of systematic factors on the outbreak outcomes of the novel COVID-19 disease in China: factor analysis study Z Cao, F Tang, C Chen, C Zhang, Y Guo, R Lin, Z Huang, Y Teng, T Xie, ... Journal of medical Internet research 22 (11), e23853, 2020 | 14 | 2020 |
| Policy updates on access to and affordability of innovative medicines in China GG Liu, J Wu, X He, Y Jiang Value in Health Regional Issues 30, 59-66, 2022 | 13 | 2022 |
Weiyi Niכתובת אימייל מאומתת בדומיין medtronic.com
